9th Annual European Medical Device Investigator Initiated Study Conference

Name: 9th Annual European Medical Device Investigator Initiated Study Conference
Start: 2024-07-10T08:00:00
End: 2024-07-11T15:40:00
Location: Sheraton Brussels Airport Hotel

10 Jul 2024

About the event

The concept of Investigator Initiated Study is not new in the MedTech industry. However, the landscape governing clinical studies has evolved significantly, introducing greater complexity. While the global prevalence of IIS is increasing, manufacturers are grappling with heightened legal, ethical, and financial intricacies. The TT European Medical Device Investigator Initiated Study Conference offers a golden opportunity to partake in highly interactive presentations enriched with real-world business examples. Engage with esteemed industry experts in real time through this intimate interactive knowledge-sharing platform.

Expect live Q&A sessions, roundtable discussions, breakout sessions, and ongoing dialogue exchanges that deliver practical insights, guidance, and invaluable networking prospects.

DAY1 08:00 – 17:15 CET | DAY2 8:30 – 15:40 CET

CPD Provider

TT LifeSciences

View member

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Event Details

9th Annual European Medical Device Investigator Initiated Study Conference

10 Jul 2024 08:0011 Jul 2024 15:40

Sheraton Brussels Airport Hotel Brussels.

TT LifeSciences

TT LifeSciences develop and deliver strategic informational programmes through training courses, conferences and seminars aimed at tightly targeted audiences across a variety of industries. Our programmes address the needs of today’s leading executives across Europe, Middle East and Asia through timely and specific content. TT LifeSciences use extensive research from across the globe to consistently deliver essential content for those we serve.